Literature DB >> 8710502

Stabilization of triple-stranded oligonucleotide complexes: use of probes containing alternating phosphodiester and stereo-uniform cationic phosphoramidate linkages.

S Chaturvedi1, T Horn, R L Letsinger.   

Abstract

Pyrimidine oligonucleotides containing alternating anionic and stereo-uniform cationic N-(dimethylamino-propyl)phosphoramidate linkages [e.g. d(T+T-)7T, d(T+T-)2(T+C-)5T and (U'+U'-)7dT, where U' is 2'-O-methyluridine)] are shown to bind to complementary double-stranded DNA segments in 0.1 M NaCl at pH 7 to form triple-stranded complexes with the pyrimidine.purine.pyrimidine motif. For each of the sequences investigated, one stereoisomer bound with higher affinity, and the other stereoisomer with lower affinity, than the corresponding all-phosphodiester oligonucleotide. The stereoisomer of d(T+T-)7T that interacted weakly with a dT.dA target in 0.1 M NaCl formed a novel dA.dA.dT triple-stranded complex with poly(dA) or d(Al5C4A15) in 1 M NaCl; in contrast, the stereoisomer that bound strongly to the dT.dA target failed to form a dA.dA.dT triple-stranded complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710502      PMCID: PMC145931          DOI: 10.1093/nar/24.12.2318

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Structure, stability, and thermodynamics of a short intermolecular purine-purine-pyrimidine triple helix.

Authors:  D S Pilch; C Levenson; R H Shafer
Journal:  Biochemistry       Date:  1991-06-25       Impact factor: 3.162

2.  The influence of single base triplet changes on the stability of a pur.pur.pyr triple helix determined by affinity cleaving.

Authors:  P A Beal; P B Dervan
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

3.  Formation of the triple-stranded polynucleotide helix, poly(A.A.U).

Authors:  S L Broitman; D D Im; J R Fresco
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.

Authors:  M Cooney; G Czernuszewicz; E H Postel; S J Flint; M E Hogan
Journal:  Science       Date:  1988-07-22       Impact factor: 47.728

5.  A strand disproportionation reaction in a helical polynucleotide system.

Authors:  H Todd Miles; J Frazier
Journal:  Biochem Biophys Res Commun       Date:  1964       Impact factor: 3.575

6.  Sequence-specific cleavage of double helical DNA by triple helix formation.

Authors:  H E Moser; P B Dervan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

7.  Polyamines favor DNA triplex formation at neutral pH.

Authors:  K J Hampel; P Crosson; J S Lee
Journal:  Biochemistry       Date:  1991-05-07       Impact factor: 3.162

8.  Oligonucleotide N-alkylphosphoramidates: synthesis and binding to polynucleotides.

Authors:  A Jäger; M J Levy; S M Hecht
Journal:  Biochemistry       Date:  1988-09-20       Impact factor: 3.162

9.  Structures for the polynucleotide complexes poly(dA) with poly (dT) and poly(dT) with poly(dA) with poly (dT).

Authors:  S Arnott; E Selsing
Journal:  J Mol Biol       Date:  1974-09-15       Impact factor: 5.469

10.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide.

Authors:  P E Nielsen; M Egholm; R H Berg; O Buchardt
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  2 in total

1.  Solid-phase synthesis of oligopurine deoxynucleic guanidine (DNG) and analysis of binding with DNA oligomers.

Authors:  B A Linkletter; I E Szabo; T C Bruice
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

2.  Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation.

Authors:  Thibaut Michel; Camille Martinand-Mari; Françoise Debart; Bernard Lebleu; Ian Robbins; Jean-Jacques Vasseur
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.